ASTRO: Penn Medicine studies point to clinical advantages of proton therapy

New data from clinical trials conducted at the Robert Proton Therapy Center demonstrate the technology’s potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumours: pancreatic, late-stage, non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue. The research is being presented today at the 57th American Society for Radiating Oncology (ASTRO) annual meeting.